Hepatitis B, Chronic Clinical Trials

276 clinical trials for Hepatitis B, Chronic across international registries, including 19 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B — RECRUITING · PHASE1
• Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions — RECRUITING · PHASE2
• Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region — RECRUITING · PHASE2
• Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens — RECRUITING · NA
• Study of AHB-171 in Chronic Hepatitis B Participants — RECRUITING · PHASE2
• Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer — RECRUITING · NA
• Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D — RECRUITING
• Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study — RECRUITING
• Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION] — RECRUITING · PHASE2
• Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients — RECRUITING · PHASE4
• National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses — RECRUITING
• Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF — RECRUITING
• Improved Sensitivity Detection of Serum HBsAg and HBsAg Reversion — RECRUITING
• A Real-world Study of Staging and Grading of Clinical Immune Status in Chronic Hepatitis B — RECRUITING
• HBsAg Declined Patients Follow-up Study — RECRUITING
• Real-world Study Optimizing Nucleotide-analogues — RECRUITING
• Efficacy of NA Combined With PEG-IFN-α2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B — RECRUITING · PHASE1
• Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) — RECRUITING
• "Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu — RECRUITING
• Safely Discontinue Antiviral Treatment in Patients With Chronic Hepatitis B — COMPLETED · PHASE4
• Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB). — ACTIVE_NOT_RECRUITING · PHASE2
• Study to Investigate the Safety and Efficacy of BRII-835 and BRII-179 Combination Therapy Treating Chronic Hepatitis B Virus (HBV) Infection — COMPLETED · PHASE2
• Wearable Patch Ultrasound Probe for Diagnosis of Liver Stiffness — NOT_YET_RECRUITING
• Bepirovirsen Liver Biopsy Study — NOT_YET_RECRUITING · PHASE2
• Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2) — COMPLETED · PHASE3
• Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1) — COMPLETED · PHASE3
• The HOPE Study: Characterizing Patients With Hepatitis B and C — ACTIVE_NOT_RECRUITING
• Study of AHB-171 in Chronic Hepatitis B Participants — NOT_YET_RECRUITING · PHASE1
• A Study to Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) Patients — COMPLETED · PHASE1
• A Real-World Study on the Efficacy and Safety of Pradefovir Mesylate Tablets in the Treatment of Chronic Hepatitis B — ACTIVE_NOT_RECRUITING
• Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection — NOT_YET_RECRUITING · PHASE1
• Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection — COMPLETED · PHASE2
• Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis — NOT_YET_RECRUITING · NA
• Phase 3 Multicenter, Randomized, Double-Blind, Study to Assess the Efficacy and Safety of Treatment with Bepirovirsen in Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B Virus (B-Well 2) — OTHER · PHASE3
• Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study — NOT_YET_RECRUITING · NA
• Entecavir Resistance-Associated Mutations in Chronic HBV Patients in Turkey (STREAM Study) — NOT_YET_RECRUITING
• Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection — TERMINATED · PHASE1
• A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B Infection — COMPLETED · PHASE1
• Phase 3 Multicenter, Randomized, Double-Blind, Study to Assess the Efficacy and Safety of Treatment with Bepirovirsen in Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B Virus (B-Well 1) — OTHER · PHASE3
• A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection — TERMINATED · PHASE2
• A Study on the Safety, Efficacy and Immune Response Following Sequential Treatment With an Anti-sense Oligonucleotide Against Chronic Hepatitis B (CHB) and Chronic Hepatitis B Targeted Immunotherapy (CHB-TI) in CHB Patients Receiving Nucleos(t)Ide Analogue (NA) Therapy — COMPLETED · PHASE2
• HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB) — TERMINATED · PHASE2
• Comparison of a Handheld Elastography Device With iLivTouch in Chronic Liver Disease Patients — NOT_YET_RECRUITING
• A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B — COMPLETED · PHASE2
• A phase 2, single-blinded, randomised, controlled multi-country study to evaluate the safety, reactogenicity, efficacy and immune response following sequential treatment with an anti-sense oligonucleotide (ASO) against chronic Hepatitis B (CHB) followed by chronic Hepatitis B targeted immunotherapy (CHB-TI) in CHB patients receiving nucleos(t)ide analogue (NA) therapy. — OTHER · PHASE2
• A Study in Chronic Hepatitis B e-Antigen Negative Participants After Discontinuation of Nucleos(t)Ide Analog (NA) Treatment — WITHDRAWN · PHASE1
• A Study of JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection — COMPLETED · PHASE2
• A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection — COMPLETED · PHASE1
• An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants — COMPLETED · PHASE2
• SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB). — COMPLETED · PHASE2

Refine this search